About LUMIQUICK DIAGNOSTICS, INC.
Lumiquick Diagnostics, Inc. is a medical diagnostics company specializing in rapid immunochromatographic assays for infectious diseases, drugs of abuse, cancer markers, cardiac markers, fertility hormones, vitamin D, oxidative stress, and biothreat agents. They offer both rapid tests and ELISA formats for various diagnostic needs.
In vitro rapid immunochromatographic assays for viral hemorrhagic fevers (Dengue, Zika, Chikungunya)Drugs of Abuse (DOA) testing in multiple formats (Test Cup, Test Card, Dip Test, Multi-panel)Cancer marker tests including Fecal Occult Blood (FOB), Alpha Fetoprotein (AFP), Prostate Specific Antigen (PSA), and Carcinoembryonic Antigen (CEA)Cardiac marker tests for qualitative determination of cardiac markers using plasma specimensFertility hormone tests for detection of hCG and LH in urineVitamin D tests for quantitative or semi-quantitative determination of 25-hydroxy Vitamin DOxidative stress tests for measurement of markers such as protein, enzyme, lipid, and DNABiothreat agent detection with LumiQuick EnviroSafe™ for on-site identification of agents like Anthrax, Botulinum, Ricin, Y.pestis, SEB, and Tularemia
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to LUMIQUICK DIAGNOSTICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.